作者：Zhong, Z.; Feijen, J.
关键字：SIPCD, symposium, controlled delivery, suzhou
论文来源：期刊
具体来源：J. Control. Release 2011, 152, 1-1.
发表时间：2011年

The past decade has witnessed an explosive progress in the development
of innovative polymers for controlled delivery that is considered
as a key to the clinical success of many classical pharmaceutics
(e.g. lipophilic anticancer drugs), modern biopharmaceutics (e.g.
therapeutic proteins, DNA and siRNA), cutting-edge diagnostic modalities
(e.g. quantum dots), as well as emerging tissue engineering and
regenerative medicine. Unlike ten years ago when the US and Europe
were dominating this specific area of research and development, Asian
countries in particular Korea, Japan, Singapore and China are now
playing an increasingly important and active role. In parallel to rapidly
growing numbers of institutions and researchers dedicated to the field of
biomedical materials and technologies, the quality of research has also
been improved significantly. Nowadays, it becomes not unusual that
high quality original research papers and novel biomedical technologies
and solutions originate from our Asian colleagues. The launching of the
first Symposium on Innovative Polymers for Controlled Delivery (SIPCD
2010, September 14–17, 2010, GardenHotel, Suzhou, China)was timely.